January 29, 2026 /

Webinar: Sarepta Therapeutics – Community Update on ELEVIDYS

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

On January 26, 2026, Sarepta Therapeutics joined PPMD for a breaking news community webinar to discuss the recently released three-year top line data for ELEVIDYS, Sarepta’s gene therapy for the treatment of Duchenne. The presentation included a review of the data, a timely discussion of what this means for the community and next steps, as well as a dedicated Q&A period.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo